baber/WOPTO huggingface dataset:
Patent DK-0500581-T3 (DK)
Inventor: SCHUNTER ROLAND
IPC: A47L13/258
Filed: 1990-11-02
Granted: 1995-06-12
Abstract: PCT No. PCT/EP90/01830 Sec. 371 Date Jul. 13, 1992 Sec. 102(e) Date Jul. 13, 1992 PCT Filed Nov. 13, 1989 PCT Pub. No. WO91/07129 PCT Pub. Date May 30, 1991.A mop head for washing or wiping floors is adapted to fit on a mop holder having two plastic flaps which can be folded back upon each other, whereby the mop head includes securing members for securing it to one end of one flap of the mop holder, with the mop head further including a fabric layer having a pouch on one short side, and a strap on the other short side, whereby the strap can be tightly stretched on the one flap end via the securing members.
Patent DK-0434832-T3 (DK)
Inventor: THIERAUCH KARL-HEINZ
IPC: A61P9/08
Filed: 1990-07-13
Granted: 1994-08-29
Abstract: DELTA <8>- and  DELTA <9>-prostaglandine derivates are disclosed, having the formula (I), in which (a) represents the residues (b) or (c); R<1> represents the groups (d), (e), COOR<4> or CONHR<5>; R<2> and R<3> represent each a hydrogen atom or a hydroxyl group, whereas the OH group may be in the  alpha - or  beta -position; X is a CH2-group, an O or S atom; W is hydrogen, -OR<6>, halogen, -CN-, -NO2, trifluoromethyl or COOR<6>, and when R<4> is hydrogen, their salts with physiologically tolerable bases.  alpha -,  beta - or  gamma -cyclodextrinclathrates are also disclosed, as well as liposome-encapsulated compounds having the formula (I), their process of production and their pharmaceutical use.
Patent DK-0467481-T3 (DK)
Inventor: ZAAGMAN DANIEL
IPC: B65D85/07
Filed: 1991-07-18
Granted: 1995-07-17
Abstract: The invention relates to a package containing a powdered detergent. According to the invention, the powdered detergent is packaged in compressed form in a gas and/or vapour tight foil. The invention further relates to a powdered detergent suitable for use in the package according to the invention, consisting of agglomerates comprising a core, in which the more hygroscopic ingredients are located, and a shell, in which the less hygroscopic ingredients are located. The invention further relates to a method for the preparation of a powdered detergent suitable for use in the package according to the invention, comprising agglomerating a part of the components of the detergent to form primary agglomerates, followed by agglomerating the primary agglomerates with the remaining component(s).
Patent DK-0537256-T3 (DK)
Inventor: OLSON KEITH E
IPC: C11D17/00
Filed: 1991-06-28
Granted: 1996-03-11
Abstract: The stability of polyvinyl films used to contain detersive systems may be enhanced by the use of a barrier coating composition to separate the film degrading components, i.e., acids, bases, and halogens, from these films. The barrier coatings may either encapsulate the individual film degrading components, or they may coat the entire detersive system.
Patent DK-0513379-T3 (DK)
Inventor: KONDO SHIRO
IPC: A61K31/445
Filed: 1991-11-29
Granted: 1996-09-30
Abstract: A pharmaceutical composition for treating gout, hyperuricemia and so forth, which contains an efficacious compound of a new category, i.e., a 2-arylthiazole derivative represented by general formula (I), wherein Ar represents (un)substituted pyridyl, thienyl, furyl, naphthyl or phenyl; X represents hydrogen, alkyl or optionally protected carboxyl; and Y represents hydrogen, alkyl, or optionally protected hydroxy or carbonyl. The invention also provides novel 2-arylthiazole derivatives included in these derivatives and pharmaceutically acceptable salts thereof. <CHEM>
Patent DK-0520534-T3 (DK)
Inventor: CANALE GIUSEPPE
IPC: F16L27/12
Filed: 1992-06-03
Granted: 1994-10-10
Abstract: The invention relates a telescopic extension for a vacuum cleaner comprising an internal tube (2), an external tube (3), and a sleeve (1), wherein the internal tube is provided with a row of notches (4) suitable for receiving a constraining element (250). The sleeve (1) comprises at least one first tubular casing (100) and one second tubular casing (110) fitted over said first tubular casing (100); said first tubular casing (100) is provided with snap-on connecting means (120, 130) by means it is connected to the external wall (9) of said external tube (3); said constraining element (250) is movably supported by said first tubular casing (100) and a manual operating means (290) of said constraining element (250) is slidingly supported by said first and second tubular casing (100, 110). <IMAGE>
Patent DK-0519055-T3 (DK)
Inventor: DAVIS MARK FRANKLIN
IPC: H04H20/88
Filed: 1992-01-08
Granted: 1997-03-24
Abstract: The invention relates to the reproduction of high-fidelity multi-dimensional sound fields intended for human hearing. More particularly, the invention relates to the decoding of signals representing such sound fields delivered by one or more delivery channels, but played back over a number of presentation channels which may differ from the number of delivery channels. In one embodiment, a subband decoder combines spectral information in the frequency domain prior to inverse filtering, thereby incurring implementation costs roughly proportional to the number of presentation channels rather than to the number of delivery channels.
Patent DK-0587645-T3 (DK)
Inventor: EVANS J M
IPC: C07D215/42
Filed: 1992-06-11
Granted: 2002-06-03
Abstract: Compounds of formula (I) or pharmaceutically acceptable salts thereof: <CHEM>  wherein: Y is C-R1 where R1 is methyl; R2 is hydrogen; R3 and R4 are each methyl; R5 is hydroxy; R6, R8 and R9 are each hydrogen; R7 is 4-fluorophenyl; the R8-N-CO-R7 group being trans to the R5 group; and X is oxygen are useful in the treatment and/or prophylaxis of anxiety and/or mania, and/or depression and/or the effects associated wit withdrawal from substances of above, and/or disorders treatable and/or preventable with anti-convulsive agents.
Patent DK-0619735-T3 (DK)
Inventor: HOLTHUIS JOSEPHUS JOHANNES MAR
IPC: C07D241/08
Filed: 1992-10-22
Granted: 2000-12-04
Abstract: A stable lyophilised preparation of ICRF-187 in which the cake of ICRF-187 is protected against the deleterious effect of light, has a moisture content of not more than about 2 %, and is obtainable by a lyophilization process using a starting solution of a therapeutically acceptable acid salt of ICRF-187 having a concentration of up to about 25 mg/ml and in which the primary drying stage lasts at least 30 hours, preferably at least 40 hours, and/or uses a primary drying temperature of from about 30  DEG C to about 40  DEG C.
Patent DK-0561183-T3 (DK)
Inventor: BOSSLET KLAUS
IPC: C12N15/09
Filed: 1993-02-25
Granted: 1999-05-25
Abstract: The invention relates to monoclonal antibodies which have high avidity and react specifically with gangliosides GD3 and GQ1b, and to the use thereof for detecting melanomas and other GD3 and GQ1b expressing tumours or tissues.
Patent DK-0581057-T3 (DK)
Inventor: LIEDTKE RAINER K DR
IPC: A61K9/06
Filed: 1993-07-05
Granted: 1999-06-21
Abstract: To improve the efficacy and tolerability of conventional topical applications for medicinal substances which have a transdermal systemic action, single-dose topical dosage forms which are ready for accurate therapeutic use are produced from suitable semisolid dosage forms. The topical single doses are pharmaceutically specified in terms of their dose, their topical spreading behaviour and their permeation properties. A plurality of the single doses which are ready for topical use is moreover accommodated in a common technical carrier container. Differentiated therapies can be designed by means of different single dosages or else combinations of active ingredients. The pharmacological active ingredients which are particularly employed are steroids, peptides, various analgesics, local anaesthetics and non-steroidal antirheumatic agents. The single-dose topical dosage form is a safe, user-friendly and slow-cost application form which makes it possible for topical therapy for systemic uses to be more accurate than hitherto achievable with conventional topical use forms.
Patent DK-0652943-T3 (DK)
Inventor: ILDSTAD SUZANNE T
IPC: A61K35/28
Filed: 1993-07-09
Granted: 2008-11-03
Abstract: The present invention relates to mammalian hematopoietic facilitatory cells (FC). In particular, it relates to the isolation, characterization and uses of the FC. The FC of the present invention can be distinguished from all other known bone marrow cells by their morphology, cell surface phenotype and (in vivo) function. It has now been established that purified hematopoietic stem cells alone or bone marrow cells depleted of FC do not readily engraft in a recipient. When co-administered with other bone marrow cells, especially the hematopoietic stem cells into a recipient, the FC enhance their engraftment, without apparent adverse biologic activities. In fact, the ability of the FC to enhance the engraftment of bone marrow cells in establishing lymphohematopoietic chimerism without producing graft versus host disease also induces donor-specific tolerance to permit the permanent acceptance of donor's cells, tissues and organs. Therefore, FC may have a wide range of applications, including, but not limited to, hematopoietic reconstitution by bone marrow transplantation for the treatment of cancers, anemias, autoimmunity, immunodeficiency, viral infections and metabolic disorders as well as facilitation of solid organ, tissue and cellular transplantation.
Patent DK-0645823-T3 (DK)
Inventor: WEBB MONTY F
IPC: H01L29/74
Filed: 1994-07-25
Granted: 1999-11-15
Abstract: An overvoltage protection device having multiple shorting dots (66) in the emitter region and multiple buried regions (72) substantially aligned with these shorting dots. The placement, number, and area of these buried regions reduce and more accurately set the overshoot voltage value of the device while maintaining the high surge capacities of the device. Further, doping types and concentrations have been modified from that known in the prior art to reduce overshoot providing a more accurate and sensitive overvoltage protection device than that known previously in the prior art. The emitter regions (68) are preferably p<+><+> doped, the upper base (70) is n<+> doped, the mid-region layer (74) is p-doped, with the burred regions (72) being p<+> doped, the lower base region (76) is n<+> doped and contains a "getter" region (78) of higher doping to reduce the leakage current. <IMAGE>
Patent DK-0727258-T3 (DK)
Inventor: HOMMERLE MARIO
IPC: B05B14/41
Filed: 1995-08-22
Granted: 2000-01-03
Abstract: The cleaning device passes in the longitudinal direction through the cabin and has a pipe system with branch pipes (16,18) extending vertically and parallel to the side walls of the cabin and having nozzles (163-166). The bottom of the cabin is formed by a discharge belt (24) running lengthwise in the cabin. Behind the pipe system is a wiper frame for wiping down the side walls and ceiling of the cabin. Outside the cabin is a separate cleaning device for cleaning the discharge belt. Slits in the two lower corner areas of the cabin communicate with side suction channels (20,22) for recovering blown off powder.
Patent DK-0719555-T3 (DK)
Inventor: OETTEL MICHAEL PROF
IPC: A61K31/4045
Filed: 1995-12-01
Granted: 2000-12-18
Abstract: A pulsatile pharmaceutical form consists of an apolar carrier contg. the pharmaceutical and a polar carrier contg. at least a fraction of the pharmaceutical. The dielectric constants of the 2 carriers is different by a factor of at least 2. The apolar carrier pref. has a dielectric constant of 20-0 (esp. 5-0) and is a hydrocarbon or a glycol or glycerol ester with an alkanoic or alkenoic acid.
Patent DK-0709371-T3 (DK)
Inventor: ANDRIEUX JEAN
IPC: C07C259/08
Filed: 1995-10-25
Granted: 1999-02-15
Abstract: O-Aryl methyl N-acyl or N-thioacyl hydroxylamine derivs. of formula ArCH2ON(R1)C(=X)R2 (I), their enantiomers and diastereoisomers are new. X = O or S; R1 = H, alkyl, cycloalkyl, cycloalkylalkyl, aryl, or arylalkyl; R2 = R21 or R22; R21 = H or alkyl, alkenyl, alkynyl, cycloalkyl or cycloalkylalkyl all of which may be substd.; R22 = alkylamino, cycloalkylamino, or cycloalkylalkylamino which may be substd. on the (cyclo)alkyl gps.; Ar = naphthyl, indolyl, benzofuranyl, or benzothiophenyl, all of which may be partially or fully hydrogenated. alkyl, alkoxy = 1-6C, alkenyl, alkynyl = 2-6C, cycloalkyl = 3-8C, and opt. substits. on these may be halo, alkyl or alkoxy. Opt. substits. on Ar gps. are one or more gps. R; R = halo, OH, Ra, -CH2Ra, -O-Ra, -CO-Ra or -O-CO-Ra; Ra = opt. substd. alkyl, alkenyl, alkynyl, opt. substd. cycloalkyl, opt. substd. cycloalkylalkyl, opt. substd. aryl or opt. substd. aralkyl; the substits. on aryl and aralkyl gps. may be halo, alkyl, alkoxy, OH and/or haloalkyl.
Patent DK-0737371-T3 (DK)
Inventor: ROTHE LUTZ
IPC: H01Q5/10
Filed: 1994-11-29
Granted: 1999-04-26
Abstract: PCT No. PCT/EP94/03957 Sec. 371 Date May 31, 1996 Sec. 102(e) Date May 31, 1996 PCT Filed Nov. 29, 1994 PCT Pub. No. WO95/15591 PCT Pub. Date Jun. 8, 1995The invention relates to a planar antenna 1 having surface resonators 5, which are connected via a supply network 6 to a supply point 7, the supply point 7 of the planar antenna 1 being connected via a coupling element 13 to an electronic circuit 12, particularly a converter, the coupling element 13 being a coaxial conductor in which the ratio, between the outer diameter of the inner conductor and the inner diameter of the outer conductor 17, changes between the supply point 7 of the supply network 6 and the terminal 11 of the electronic circuit 12.
Patent DK-0765478-T3 (DK)
Inventor: TSENG-LAW JANET
IPC: C12N5/06
Filed: 1995-06-13
Granted: 1999-05-03
Abstract: The invention provides a nonenzymic method for the release of cells which have been selected from a heterogeneous cell suspension by antibody-mediated binding to beads or other solid support. The method entails forming within the cell suspension a complex comprising the solid support linked to a primary monoclonal antibody, which in turn is bound to a cell surface antigen on the target cells. The complex is separated from the cell suspension, and then contacted with a specific peptide which binds to the primary antibody, displacing the antibody from the cell surface antigen, thereby releasing the target cell from the complex. The invention also provides methods for positive/negative cell selection wherein target cells having a first antigen are selected from a heterogeneous cell suspension containing undesired cells having a second antigen.
Patent DK-0883778-T3 (DK)
Inventor: SCHMID CHRISTOPH
IPC: F23J7/00
Filed: 1996-08-20
Granted: 2001-08-27
Abstract: A process is disclosed for incinerating sewage sludge (1). Sewage sludge is dried by a drier (30) heated by means of a heat transfer medium, then incinerated in a furnace, preferably a cycloid furnace. The heat transfer medium is heated during the incineration process and the furnace smoke gas is dedusted and purified. In order to discharge non-contaminated solids, a basic additive (9a, 9b) is fed to the furnace, the smoke gas is subjected to a first dedusting (17) and cooling (13) process, and its heat is again removed by cooling it down to a lower temperature higher than the limit cooling temperature of the smoke gas. Another basic additive (22) is then added to the smoke gas before the smoke gas is dedusted (23) in a filter. The first dedusting process (17) is carried out before heat is removed for drying the sewage sludge.
Patent DK-0879056-T3 (DK)
Inventor: TAM ROBERT
IPC: A61K45/06
Filed: 1997-01-21
Granted: 2002-08-19
Abstract: Ribavirin3 is administered to a patient in a dosage range which is effective to modulate lymphokine expression in activated T cells. In particular, Ribavirin3 is used to suppress Th2-mediated T cell responses and promote Th1-mediated T cell response. In other aspects of the invention, one or more Ribavirin3 analogs are administered to a patient in a dosage range which is effective to modulate lymphokine expression in activated T cells. The Ribavirin3 analog(s) may be used to suppress or enhance Th1 or Th2-mediated T cell responses.
Patent DK-0914157-T3 (DK)
Inventor: FELDMANN MARC
IPC: A61K38/00
Filed: 1997-08-01
Granted: 2006-01-30
Abstract: Use of a tumour necrosis factor (TNF) antagonist for the preparation of a medicament for treatment of a TNF-mediated disease, wherein the TNF antagonist is to be administered as adjunctive therapy to methotrexate.
Patent DK-1038152-T3 (DK)
Inventor: SCHMAKER BRUCE E
IPC: F42B25/00
Filed: 1997-12-11
Granted: 2004-12-13
Abstract: A target penetrating aerial bomb including a penetrating body (24) shaped for improved target penetration, having a narrower impact profile at approximately the same weight as an existing bomb. An aerodynamic shroud (40) encases the penetrating body (24) and emulates the aerodynamic shape of the existing bomb, and the weight, center of gravity, and moments of inertia of the bomb closely approximate those properties of the existing bomb. The bomb according to the invention may be qualified for flight by similarity to the existing bomb, and thus avoid lengthy and costly qualification procedures.
Patent DK-0954867-T3 (DK)
Inventor: COGEN JEFFREY MORRIS
IPC: H01B3/44
Filed: 1998-01-23
Granted: 2002-02-18
Abstract: A cable construction comprises the following components: (i) a plurality of insulated electrical conductors having interstices therebetween, said insulation comprising (a) one or more polyolefins selected from the group consisting of polyethylene, polypropylene, and mixtures thereof, and, blended therewith, (b) a mixture containing one or more alkylhydroxy-phenylalkanoyl hydrazines and one or two functionalized hindered amines; (ii) hydrocarbon cable filler grease within the interstices; and (iii) a sheath surrounding components (i) and (ii) wherein said hindered amines have the following structural formulae:    <IMAGE>  Formula I  wherein n is about 2 to about 12; R is CxHyOz wherein x is about 2 to about 6, y is about 4 to about 16, and z is zero to about 3;    <IMAGE>  Formula II  wherein m is about 2 to about 30; n is about 2 to about 30; and x is about 1 to about 30; or    <IMAGE>  Formula III  wherein n is about 2 to about 20.
Patent DK-0980523-T3 (DK)
Inventor: CHRISTOPHERSEN PALLE
IPC: G01N15/14
Filed: 1998-04-29
Granted: 2007-04-30
Abstract: The present invention relates to an automatic electrode position apparatus for connecting an electrode to a cell. The invention further provides methods for utilizing the apparatus of the invention. Apparatus and methods are described for studying electrical activities in cell membranes. These methods are especially useful in large scale screening programs in the pharmaceutical industry.
Patent DK-0999764-T3 (DK)
Inventor: MUELLER KARL
IPC: A43B21/26
Filed: 1998-07-03
Granted: 2003-08-25
Abstract: A shoe includes a sole (2) that extends from a rear heel area (6) through a metatarsal area (7) to a front ball or toe area (8), the sole being composed of a sole body (10) and a sole covering (11) formed on the underside of the sole body (10) and a recess (13) extending approximately from metatarsal area (7) to heel area (6). The recess is provided between sole body (10) and sole covering (11), with the area of sole covering (11) associated with recess (13) forming a pivoting element (18) designed to pivot around a pivot axis (20) located in the end area of recess (13) facing metatarsal area (7). The end area of recess (13) facing metatarsal area (7) is defined by a tip (13a) of recess (13), and the pivot axis (20) is located in the area between a lengthwise center of shoe (1) and heel area (6), with heel area (6) extending over approximately one-third of the length of shoe (1). At least one material element (25) is located in recess (13), the material element (25) being made of a flexible, soft material and being made approximately wedge-shaped or approximately in the shape of a circular section.
Patent DK-1032929-T3 (DK)
Inventor: FAGAN DAVID
IPC: G08G1/0967
Filed: 1998-11-19
Granted: 2002-10-14
Abstract: A speed limit indicator for, for example, a four-lane highway (1) having left lanes (3) and right lanes (4), the direction of travel indicated by the arrows. Road markings (11, 12 and 13) of different colors are used to provide an indication of the speed limit for the particular speed zone. The invention also provides a transmitter which is sited usually at the entrance to a speed zone and a receiver in a vehicle which are used to signal the speed limit to a driver.
Patent DK-1056345-T3 (DK)
Inventor: ARNAUT FILIP
IPC: A21D2/00
Filed: 1999-02-18
Granted: 2002-10-14
Abstract: The present invention is related to a bread improver in the form of a powder, characterised in that it is made of agglomerated particles having a mean particle size of at least 250  mu m. <??>The present invention is also related to the preparation method of said bread improver. <IMAGE>
Patent DK-1131169-T3 (DK)
Inventor: RINNE KARI
IPC: B08B9/04
Filed: 1999-11-17
Granted: 2003-09-01
Abstract: A method for cleaning industrial pipe systems, preferably pipe systems used in food industry, such as meat, fish and vegetable industry. The method for cleaning industrial pipe systems, includes the steps of feeding a detergent together with liquid and granules, having a diameter, in batches only into a portion of a pipe, having a cross-section, to be cleaned, whereby one wash batch has a volume in liters, which is 0.05-0.3 times the numerical value of the cross-section in square centimeters of the pipe, creating a negative pressure in the pipe, and bringing the wash batch to flow in the pipe by means of the negative pressure for cleaning and mechanically treating the walls of the pipe.
Patent ES-2219210-T3 (ES)
Title: Modulo de airbag que amortigua las vibraciones.
Inventor: FRISCH RALPH
IPC: B60R21/20
Filed: 2000-02-04
Granted: 2004-12-01
Abstract: Módulo de airbag para un volante de dirección de automóvil con un saco de gas (1), un generador de gas (2), una tapa abatible (3), un soporte del generador (4) y medios (5) para unir las mencionadas piezas del módulo formando una unidad constructiva, donde una chapa de montaje (6) de forma anular y un cilindro de montaje (9), dirigido en paralelo al eje del volante de dirección y fabricado en un material elástico, están dispuestos en el soporte del generador (4), caracterizado porque los bordes libres (10, 11) unen el cilindro de montaje por una parte con la chapa de montaje (6) y por otra parte con el generador de gas (2).
Patent ES-2221602-T3 (ES)
Inventor: DAUBENSPECK TIMOTHY H
IPC: H01L21/82
Filed: 2000-04-04
Granted: 2005-01-01
Abstract: A high laser absorption copper fuse can minimize the laser energy needed to delete the fuse portion of the conductor. Significantly, this type of fuse structure would allow for formation of copper fuses that can be deleted with appreciably less incident energy, mainly by increasing the absorption of the fuse link at the given incident laser energies. A metal wiring line contains a fuse link segment wherein the fuse link segment is composed of a stack of at least two metals. The underlayer material in the stack of metals is the primary electrical copper conductor, and the overlayer metal, also an electrical conductor, primarily tungsten or titanium-tungsten in composition, has predetermined thickness and optical properties chosen such that the combination of the overlayer metal with the underlayer metal provides for high absorption characteristics to incident infrared energy. Fabrication methods for providing overlaying material to the entire fuse link line, or to selective portions of the fuse link line are presented. <IMAGE>